A small subset will continue GLP-1s longer, although many transition to a maintenance rhythm: often less frequent dosing (for example, a dose every 34 weeks) once target body composition and glucose control are achieved
Helmholtz Munich is involved in numerous collaborations with a multitude of companies and institutions, worldwide
Most clinical endocrinologists treating obesity prescribe 1,500 to 2,000 IU daily as a maintenance dose, citing evidence that people with higher BMI require larger oral doses to achieve the same serum concentrations as lean individuals [6]
GLP-1 receptor agonists offer a safe, medically supported path to weight loss for individuals who have struggled with traditional methods
So why, then, would we use Methionine (thought to activate mTOR) in our B12/MIC formulation
Is it unsafe to reuse plastic water bottles